Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and StockBased Compensation (Details 3)

v3.20.2
Stockholders Equity and StockBased Compensation (Details 3)
9 Months Ended
Sep. 30, 2020
$ / shares
shares
Stockholders Equity and StockBased Compensation  
Shares, non-vested, beginning | shares 84,873
Shares, Granted | shares 7,634
Shares, vested | shares (41,552)
Shares, Forfeited | shares (1,229)
Shares, non-vested, end of period | shares 49,726
Weighted average exercise price, Beginning $ 10.73
Weighted average exercise price, granted 4.45
Weighted average exercise price, vested 10.80
Weighted average exercise price, forfeited 10.80
Weighted average exercise price, end of period 9.71
Weighted average fair value grant date, beginning 5.15
Weighted average fair value grant date, granted 3.28
Weighted average fair value grant date, vested 8.29
Weighted average fair value grant date, forfeited 8.33
Weighted average fair value grant date, end of period $ 7.44